• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[胞磷胆碱在脑卒中早期及恢复阶段的疗效评估]

[The assessment of the efficacy of citicoline in the early and recovery stages of stroke].

作者信息

Shavlovskaya O A

机构信息

Sechenov First Moscow State Medical University, Moscow, Russia.

出版信息

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(6):93-97. doi: 10.17116/jnevro20161166193-97.

DOI:10.17116/jnevro20161166193-97
PMID:28635796
Abstract

The review presents data on the evaluation of the efficacy of citicoline in ischemic stroke. It presents research findings about the effect of citicoline to reduce infarct volume in animal models of cerebral ischemia. Long-term treatment of CDP-choline initiated 24 hours after stroke contributes to the increased plasticity of neurons in intact brain areas (functionally associated with the damaged areas) and accelerated functional recovery. The oral administration of citicoline within the first 24 hours after the onset of symptoms in moderate and severe stroke increases the probability of complete recovery in 3 months. A neuroprotective effect of citicoline in acute and early restorative stages of stroke accompanied by cognitive impairment was shown. According to the results of clinical trials of the dosage regimen, citicoline administered in the dose of 1000 mg/day for 8 weeks accelerates the regression of hemiplegia; the intravenous injection in the dose of 750 mg/day for 10 days, starting with the first 48 hours of stroke onset symptoms, promotes the recovery of motor and cognitive functions; the intravenous injection in the dose of 1 g within 14 days improves the recovery of consciousness, general condition and functional status.

摘要

该综述展示了关于胞磷胆碱在缺血性卒中疗效评估的数据。它呈现了胞磷胆碱在脑缺血动物模型中减少梗死体积作用的研究结果。卒中后24小时开始长期使用胞磷胆碱有助于完整脑区(与受损区域功能相关)神经元可塑性增加及功能恢复加速。在中度和重度卒中症状出现后的头24小时内口服胞磷胆碱可增加3个月内完全恢复的可能性。已表明胞磷胆碱在伴有认知障碍的卒中急性和早期恢复阶段具有神经保护作用。根据剂量方案的临床试验结果,每天1000毫克剂量的胞磷胆碱持续给药8周可加速偏瘫的消退;从卒中发作症状的头48小时开始,每天750毫克剂量静脉注射10天可促进运动和认知功能的恢复;14天内每天1克剂量静脉注射可改善意识、一般状况和功能状态的恢复。

相似文献

1
[The assessment of the efficacy of citicoline in the early and recovery stages of stroke].[胞磷胆碱在脑卒中早期及恢复阶段的疗效评估]
Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(6):93-97. doi: 10.17116/jnevro20161166193-97.
2
Citicoline (CDP-choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental stroke.胆碱胞苷二磷酸(CDP-胆碱)可增加 Sirtuin1 的表达,同时对实验性中风具有神经保护作用。
J Neurochem. 2013 Sep;126(6):819-26. doi: 10.1111/jnc.12269. Epub 2013 May 13.
3
Neuroprotection and recovery: recent data at the bench on citicoline.神经保护和恢复:细胞磷胆碱的最新实验室数据。
Stroke. 2011 Jan;42(1 Suppl):S33-5. doi: 10.1161/STROKEAHA.110.597435. Epub 2010 Dec 16.
4
Citicoline: pharmacological and clinical review, 2006 update.胞磷胆碱:药理与临床综述,2006年更新版
Methods Find Exp Clin Pharmacol. 2006 Sep;28 Suppl B:1-56.
5
Citicoline preclinical and clinical update 2009-2010.2009-2010 年胞磷胆碱的临床前和临床最新进展。
Stroke. 2011 Jan;42(1 Suppl):S36-9. doi: 10.1161/STROKEAHA.110.605568. Epub 2010 Dec 16.
6
Citicoline in vascular cognitive impairment and vascular dementia after stroke.胞磷胆碱治疗脑卒中后血管性认知障碍和血管性痴呆
Stroke. 2011 Jan;42(1 Suppl):S40-3. doi: 10.1161/STROKEAHA.110.606509. Epub 2010 Dec 16.
7
Efficacy of citicoline as an acute stroke treatment.胞磷胆碱作为急性脑卒中治疗药物的疗效。
Expert Opin Pharmacother. 2009 Apr;10(5):839-46. doi: 10.1517/17460440902835475.
8
Citicoline for Acute Ischemic Stroke: A Systematic Review and Formal Meta-analysis of Randomized, Double-Blind, and Placebo-Controlled Trials.胞磷胆碱用于急性缺血性卒中:随机、双盲、安慰剂对照试验的系统评价与正式荟萃分析
J Stroke Cerebrovasc Dis. 2016 Aug;25(8):1984-96. doi: 10.1016/j.jstrokecerebrovasdis.2016.04.010. Epub 2016 May 24.
9
Citicoline in pre-clinical animal models of stroke: a meta-analysis shows the optimal neuroprotective profile and the missing steps for jumping into a stroke clinical trial.在脑卒中的临床前动物模型中使用胞磷胆碱:一项荟萃分析显示出最佳的神经保护谱和进入脑卒中临床试验的缺失步骤。
J Neurochem. 2012 Oct;123(2):217-25. doi: 10.1111/j.1471-4159.2012.07891.x. Epub 2012 Aug 23.
10
[The efficacy of recognan in the early stage of ischemic stroke].[瑞格纳(Recognan)在缺血性中风早期的疗效]
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10):44-48. doi: 10.17116/jnevro201711710144-48.